Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE

Pooled data from two large registries, Cubicin？ Outcomes Registry and Experience (CORE; USA) and European Cubicin？ Outcomes Registry and Experience (EU-CORE; Europe, Latin America, and Asia), were analyzed to determine the characteristics and clinical outcomes of daptomycin therapy in patients with Gram-positive infections across wide geographical regions